GeneTx Biotherapeutics LLC
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From GeneTx Biotherapeutics LLC
The Phase III clinical trial showed a noticeable placebo effect compared with OV101.
Former Novartis CEO Jimenez co-founded Aditum with former NIBR president Mark Fishman; they raised $133m and are launching Tempero Bio. Also, Atea, Galecto and SQZ went public along with one more health care SPAC, Royalty Pharma upped its Vertex royalty revenues and Mirati’s FOPO raised $926.3m.
A review of the Phoenix '97 CEO conference shows there's a long way to go in bridging the communication gap between large and small companies.